Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 1/20 | 0.43 |
| ▸ | PDE1A | P54750 | 1/20 | 0.41 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.41 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | L3MBTL4 | Q8NA19 | 1/20 | 0.38 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9386393 | 0.87 | ADRB3 (0.44) | ADRB3 | |
| SCHEMBL9385975 | 0.87 | HTR1B (0.41) | ADRB3PDE1APDE1BPDE4DPDE7A | |
| SCHEMBL9384972 | 0.84 | ADRB3 (0.40) | ADRB3PDE4DALDH1A1 | |
| SCHEMBL9385137 | 0.84 | ADRB3 (0.40) | ADRB3PDE4DALDH1A1 | |
| SCHEMBL9385378 | 0.83 | ALDH1A1 (0.39) | ADRB3PDE1APDE1BPDE4DPDE7A | |
| SCHEMBL9388851 | 0.83 | TIPARP (0.39) | ADRB3PDE1APDE1BPDE4DPDE7A | |
| SCHEMBL7097075 | 0.81 | KDM4E (0.50) | ADRB3PDE4DALDH1A1 | |
| SCHEMBL9388829 | 0.80 | ADRB3 (0.43) | ADRB3 | |
| SCHEMBL9389540 | 0.78 | ADRB3 (0.46) | ADRB3 | |
| SCHEMBL9386881 | 0.77 | ADRB1 (0.55) | PDE1APDE1BPDE4DPDE7APDE1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1994003425-A2 | CARBOSTYRIL DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIA | SYNTEX (U.S.A.) INC. (US) | 1994-02-17 | — | — | WO | disclosed |